vs

Side-by-side financial comparison of OPKO HEALTH, INC. (OPK) and TRICO BANCSHARES (TCBK). Click either name above to swap in a different company.

OPKO HEALTH, INC. is the larger business by last-quarter revenue ($148.5M vs $109.4M, roughly 1.4× TRICO BANCSHARES ). TRICO BANCSHARES runs the higher net margin — 251.6% vs -21.1%, a 272.7% gap on every dollar of revenue. On growth, TRICO BANCSHARES posted the faster year-over-year revenue change (9.0% vs -19.2%). TRICO BANCSHARES produced more free cash flow last quarter ($127.9M vs $-28.6M). Over the past eight quarters, TRICO BANCSHARES 's revenue compounded faster (5.4% CAGR vs -7.5%).

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

Trico Bancshares is a U.S.-headquartered regional bank holding company operating Tri Counties Bank. It offers a full range of retail and commercial banking services including deposit products, mortgages, small business loans, and wealth management, primarily serving consumers and SMEs in Northern California.

OPK vs TCBK — Head-to-Head

Bigger by revenue
OPK
OPK
1.4× larger
OPK
$148.5M
$109.4M
TCBK
Growing faster (revenue YoY)
TCBK
TCBK
+28.2% gap
TCBK
9.0%
-19.2%
OPK
Higher net margin
TCBK
TCBK
272.7% more per $
TCBK
251.6%
-21.1%
OPK
More free cash flow
TCBK
TCBK
$156.5M more FCF
TCBK
$127.9M
$-28.6M
OPK
Faster 2-yr revenue CAGR
TCBK
TCBK
Annualised
TCBK
5.4%
-7.5%
OPK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OPK
OPK
TCBK
TCBK
Revenue
$148.5M
$109.4M
Net Profit
$-31.3M
$33.6M
Gross Margin
43.1%
Operating Margin
-25.8%
42.6%
Net Margin
-21.1%
251.6%
Revenue YoY
-19.2%
9.0%
Net Profit YoY
-322.8%
15.8%
EPS (diluted)
$-0.04
$1.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPK
OPK
TCBK
TCBK
Q4 25
$148.5M
$109.4M
Q3 25
$151.7M
$107.6M
Q2 25
$156.8M
$103.6M
Q1 25
$150.0M
$98.6M
Q4 24
$183.6M
$100.4M
Q3 24
$173.6M
$99.1M
Q2 24
$182.2M
$97.9M
Q1 24
$173.7M
$98.5M
Net Profit
OPK
OPK
TCBK
TCBK
Q4 25
$-31.3M
$33.6M
Q3 25
$21.6M
$34.0M
Q2 25
$-148.4M
$27.5M
Q1 25
$-67.6M
$26.4M
Q4 24
$14.0M
$29.0M
Q3 24
$24.9M
$29.1M
Q2 24
$-10.3M
$29.0M
Q1 24
$-81.8M
$27.7M
Gross Margin
OPK
OPK
TCBK
TCBK
Q4 25
43.1%
Q3 25
32.9%
Q2 25
31.5%
Q1 25
28.4%
Q4 24
46.1%
Q3 24
23.1%
Q2 24
28.4%
Q1 24
24.2%
Operating Margin
OPK
OPK
TCBK
TCBK
Q4 25
-25.8%
42.6%
Q3 25
31.7%
43.2%
Q2 25
-38.3%
36.5%
Q1 25
-44.8%
35.8%
Q4 24
-18.0%
38.7%
Q3 24
8.2%
39.8%
Q2 24
-33.9%
40.0%
Q1 24
-41.2%
38.3%
Net Margin
OPK
OPK
TCBK
TCBK
Q4 25
-21.1%
251.6%
Q3 25
14.3%
31.6%
Q2 25
-94.7%
26.6%
Q1 25
-45.1%
26.7%
Q4 24
7.6%
221.4%
Q3 24
14.3%
29.3%
Q2 24
-5.7%
29.7%
Q1 24
-47.1%
28.2%
EPS (diluted)
OPK
OPK
TCBK
TCBK
Q4 25
$-0.04
$1.02
Q3 25
$0.03
$1.04
Q2 25
$-0.19
$0.84
Q1 25
$-0.10
$0.80
Q4 24
$0.02
$0.88
Q3 24
$0.03
$0.88
Q2 24
$-0.01
$0.87
Q1 24
$-0.12
$0.83

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPK
OPK
TCBK
TCBK
Cash + ST InvestmentsLiquidity on hand
$364.4M
$157.0M
Total DebtLower is stronger
$344.0M
Stockholders' EquityBook value
$1.3B
$1.3B
Total Assets
$1.9B
$9.8B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPK
OPK
TCBK
TCBK
Q4 25
$364.4M
$157.0M
Q3 25
$412.0M
$298.8M
Q2 25
$267.3M
$314.3M
Q1 25
$428.8M
$308.3M
Q4 24
$426.6M
$145.0M
Q3 24
$400.1M
$320.1M
Q2 24
$40.6M
$206.6M
Q1 24
$75.6M
$82.8M
Total Debt
OPK
OPK
TCBK
TCBK
Q4 25
$344.0M
Q3 25
$344.2M
Q2 25
$343.3M
Q1 25
$439.2M
Q4 24
$437.2M
Q3 24
$441.0M
Q2 24
$201.9M
Q1 24
$350.1M
Stockholders' Equity
OPK
OPK
TCBK
TCBK
Q4 25
$1.3B
$1.3B
Q3 25
$1.3B
$1.3B
Q2 25
$1.3B
$1.3B
Q1 25
$1.3B
$1.3B
Q4 24
$1.4B
$1.2B
Q3 24
$1.4B
$1.2B
Q2 24
$1.4B
$1.2B
Q1 24
$1.3B
$1.2B
Total Assets
OPK
OPK
TCBK
TCBK
Q4 25
$1.9B
$9.8B
Q3 25
$2.0B
$9.9B
Q2 25
$2.0B
$9.9B
Q1 25
$2.1B
$9.8B
Q4 24
$2.2B
$9.7B
Q3 24
$2.3B
$9.8B
Q2 24
$2.0B
$9.7B
Q1 24
$2.0B
$9.8B
Debt / Equity
OPK
OPK
TCBK
TCBK
Q4 25
0.27×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.33×
Q4 24
0.32×
Q3 24
0.31×
Q2 24
0.14×
Q1 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPK
OPK
TCBK
TCBK
Operating Cash FlowLast quarter
$-25.9M
$133.3M
Free Cash FlowOCF − Capex
$-28.6M
$127.9M
FCF MarginFCF / Revenue
-19.3%
116.9%
Capex IntensityCapex / Revenue
1.8%
4.9%
Cash ConversionOCF / Net Profit
3.96×
TTM Free Cash FlowTrailing 4 quarters
$-190.8M
$222.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPK
OPK
TCBK
TCBK
Q4 25
$-25.9M
$133.3M
Q3 25
$-34.6M
$45.1M
Q2 25
$-83.4M
$29.2M
Q1 25
$-34.6M
$24.5M
Q4 24
$-44.4M
$109.7M
Q3 24
$-77.1M
$28.6M
Q2 24
$-26.4M
$31.8M
Q1 24
$-35.6M
$25.1M
Free Cash Flow
OPK
OPK
TCBK
TCBK
Q4 25
$-28.6M
$127.9M
Q3 25
$-37.8M
$43.2M
Q2 25
$-86.7M
$28.2M
Q1 25
$-37.7M
$22.8M
Q4 24
$-49.8M
$105.2M
Q3 24
$-85.0M
$27.3M
Q2 24
$-33.7M
$30.8M
Q1 24
$-40.0M
$24.1M
FCF Margin
OPK
OPK
TCBK
TCBK
Q4 25
-19.3%
116.9%
Q3 25
-24.9%
40.2%
Q2 25
-55.3%
27.2%
Q1 25
-25.2%
23.1%
Q4 24
-27.1%
104.8%
Q3 24
-49.0%
27.6%
Q2 24
-18.5%
31.5%
Q1 24
-23.0%
24.4%
Capex Intensity
OPK
OPK
TCBK
TCBK
Q4 25
1.8%
4.9%
Q3 25
2.1%
1.7%
Q2 25
2.1%
1.0%
Q1 25
2.1%
1.7%
Q4 24
2.9%
4.5%
Q3 24
4.6%
1.3%
Q2 24
4.0%
1.0%
Q1 24
2.6%
1.0%
Cash Conversion
OPK
OPK
TCBK
TCBK
Q4 25
3.96×
Q3 25
-1.60×
1.33×
Q2 25
1.06×
Q1 25
0.93×
Q4 24
-3.17×
3.78×
Q3 24
-3.10×
0.98×
Q2 24
1.10×
Q1 24
0.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

TCBK
TCBK

Segment breakdown not available.

Related Comparisons